Dr. Reddy’s Laboratories Ltd

Hyderabad, Oct. 29 (Maxim News): Dr. Reddy’s Laboratories Ltd., announced its partnership with Biotechnology Industry Research Assistance Council (BIRAC), Department of Biotechnology (DBT), Government of India, for advisory support on…

Hyderabad, Oct.20 (Maxim News): Dr. Reddy’s Laboratories Ltd. today announced the re-launch of over-the-counter (OTC) Famotidine Tablets USP, 10 mg and 20 mg, the store-brand equivalents of Original Strength and Maximum Strength Pepcid AC,…

Hyderabad, Oct.17 (Maxim News): Dr. Reddy’s Laboratories Ltd. and Russian Direct Investment Fund (RDIF) today announced that they have received approval from the Drug Control General of India (DCGI) to conduct an adaptive phase 2/3 human…

Hyderabad, oct.3 (Maxim News): India and Princeton, NJ, USA. October 3, 2020 - Dr. Reddy’s Laboratories Ltd. today announced the launch of a generic version of Sapropterin Dihydrochloride Tablets, for Oral Use.

Hyderabad, sept.26 (Maxim News): Dr. Reddy's Laboratories Ltd. today announced the launch of Dimethyl Fumarate Delayed-Release Capsules, a therapeutic equivalent generic version of Tecfidera® (dimethyl fumarate) Delayed-Release Capsules,…